Edition:
India

Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

47.95USD
19 Jul 2019
Change (% chg)

-- (--)
Prev Close
$47.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
227,567
52-wk High
$59.75
52-wk Low
$33.56

About

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008,... (more)

Overall

Beta: 2.01
Market Cap(Mil.): $1,207.95
Shares Outstanding(Mil.): 31.54
Dividend: --
Yield (%): --

Financials

Zogenix's seizure drug filing fails to pass U.S. FDA scrutiny

The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc's treatment for seizures associated with Dravet syndrome, a rare form of childhood epilepsy.

09 Apr 2019

UPDATE 2-Zogenix's seizure drug filing fails to pass U.S. FDA scrutiny

April 8 The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc's treatment for seizures associated with Dravet syndrome, a rare form of childhood epilepsy.

09 Apr 2019

U.S. FDA refuses to review Zogenix's seizure treatment

April 8 The U.S. Food and Drug Administration on Monday refused to review the marketing application for Zogenix Inc's treatment for seizures associated with Dravet syndrome, a rare form of childhood epilepsy, the company said. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

09 Apr 2019

Earnings vs. Estimates